Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06390267 · ClinicalTrials.gov registry record · NA
Effect of Transcutaneous Auricular Neurostimulation on Cognitive Performance in a Laboratory Model of Acute Stress Reaction
A NA study, sponsored by Spark Biomedical.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT06390267 is a NA study that has completed, run by Spark Biomedical. The registered enrollment target is 43 participants.
The verdict
NCT06390267, a NA study, has completed, sponsored by Spark Biomedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The objective of this study is to test the effects of transcutaneous auricular neurostimulation (tAN) in treating or preventing performance degradation after an acute stressor.
Interventions
- DEVICE Sparrow Hawk (Active)
- DEVICE Sparrow Hawk (Sham)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2024-11-26 |
| Est. Completion | 2025-06-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06390267
The ClinicalTrials.gov registry entry for NCT06390267 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spark Biomedical, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sparrow Hawk (Active) is the first listed.
NCT06390267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06390267 about?
NCT06390267 is a clinical study titled "Effect of Transcutaneous Auricular Neurostimulation on Cognitive Performance in a Laboratory Model of Acute Stress Reaction". The objective of this study is to test the effects of transcutaneous auricular neurostimulation (tAN) in treating or preventing performance degradation after an acute stressor.
What is the current status of trial NCT06390267?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2024-11-26. Estimated completion is 2025-06-18.
What interventions are being tested in trial NCT06390267?
The interventions under investigation include: Sparrow Hawk (Active) (DEVICE), Sparrow Hawk (Sham) (DEVICE).
Who is sponsoring clinical trial NCT06390267?
This trial is sponsored by Spark Biomedical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.